Guizhi Lu
Impact in
-
- Thyroid Disorders and Treatments
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- Glycosylation and Glycoproteins Research 5
-
- T-cell and B-cell Immunology 3
- Complement system in diseases 2
- Co-authors
- Xiaohui Guo (21 shared papers)Ying Gao (18 shared papers)Yanming Gao (12 shared papers)Nan Yu (10 shared papers)Mingming Liu (4 shared papers)Ting Li (4 shared papers)Ning Sun (2 shared papers)Qiujie Li (2 shared papers)
- Journals
- International Immunopharmacology (4 papers)European Thyroid Journal (3 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Clinical Endocrinology (2 papers)Molecular and Cellular Endocrinology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Guizhi Lu
30 papers receiving 297 citations
Peers
Comparison fields: 5 of 77
- Research and Theory 6
- Endocrinology, Diabetes and Metabolism 66
- Rheumatology 47
- Immunology 55
- Toxicology 7
Countries citing papers authored by Guizhi Lu
This map shows the geographic impact of Guizhi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guizhi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guizhi Lu more than expected).
Fields of papers citing papers by Guizhi Lu
This network shows the impact of papers produced by Guizhi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guizhi Lu. The network helps show where Guizhi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guizhi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 41 | |
| 2 | 2014 | 29 | |
| 3 | 2013 | 19 | |
| 4 | 2023 | 19 | |
| 5 | 2016 | 16 | |
| 6 | 2018 | 16 | |
| 7 | 2016 | 15 | |
| 8 | 2013 | 14 | |
| 9 | 2011 | 13 | |
| 10 | 2017 | 10 | |
| 11 | 2016 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2016 | 8 | |
| 14 | [Detection of the anti-cancer biological effect of naphthoquinone pigment-LIII]. | 1990 | 8 |
| 15 | 2022 | 7 | |
| 16 | 2017 | 7 | |
| 17 | [Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen]. | 2007 | 6 |
| 18 | [Distribution and significance of IgG subclasses of serum antithyroglobulin antibody in Hashimoto thyroiditis]. | 2008 | 6 |
| 19 | 2018 | 6 | |
| 20 | 2015 | 6 |
About Guizhi Lu
Guizhi Lu is a scholar working on Molecular Biology, Immunology, Rheumatology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 30 papers that have together received 300 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (5 papers), IgG4-Related and Inflammatory Diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), T-cell and B-cell Immunology (3 papers), Bullying, Victimization, and Aggression (2 papers), Complement system in diseases (2 papers), Thyroid Disorders and Treatments (2 papers) and Diabetes Management and Research (1 paper). The work is most often cited by research in Research and Theory (6 citations), Endocrinology, Diabetes and Metabolism (66 citations), Rheumatology (47 citations), Immunology (55 citations) and Toxicology (7 citations). Guizhi Lu has collaborated with scholars based in China and United States. Frequent co-authors include Xiaohui Guo, Ying Gao, Yanming Gao, Nan Yu, Mingming Liu, Ting Li, Ning Sun, Qiujie Li, Yang Yu and Yalei Liu. Their work appears in journals such as International Immunopharmacology, European Thyroid Journal, The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and Molecular and Cellular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.